---
category: news
title: "BERG To Conduct Phase Two Trial For Treatment Of Deadly Glioblastoma Multiforme [GBM]"
excerpt: "BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced with leading cancer centers that the Federal Drug Administration [FDA] has authorized a phase 2 trial in glioblastoma multiforme [GBM] patients in neo-adjuvant settings using BERGâ€™s BPM 31510."
publishedDateTime: 2021-03-22T18:01:00Z
originalUrl: "https://apnews.com/press-release/pr-newswire/science-business-medical-research-corporate-news-biology-1c39adcc9055b0496cf46fefc70205ed"
webUrl: "https://apnews.com/press-release/pr-newswire/science-business-medical-research-corporate-news-biology-1c39adcc9055b0496cf46fefc70205ed"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "dpXywR9kCjxhZYSTFvje+iTXJN3iES9GVFhwqIm8YuNMpNkYidHYf5LH+r6/+mz4NliuftkCmnn6WfoUXxkaCayXqXJFB8yYbiocHIXlHhQ0ceIY0oFvzlMzB5MTPaZs5k+eHONNBjlQK9cPuN6xDLgZrNrqaMhMmObeE3g0e8O6wUoYnlsTfcwORpD1P2gdO379jhJOzPxwrqqZEsNDjG+g/nwtvzq1HOqRFDbD4Kgw3Ngbg8PT2ROwNv/mRlK+Yc7RmrfD+tyixHceJM0MiRoIj8rgzj0k4raC6s2fe80/xP68Vkopuq4ypZmJjTslmNpgpOppHTTUSdw/SyLsf4N04sm6jcTRVbIuvkE21i4=;oe9tvFk88PjulHccnWoPzQ=="
---

